Previous 10 | Next 10 |
home / stock / mcujf / mcujf news
WINNIPEG , May 6, 2020 /PRNewswire/ - Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH, OTC:MCUJF), a cardiovascular pharmaceutical company, will release financial results for the quarter ended March 31, 2020 on Tuesday, May 12, 2020 . The first quarter financial statements will b...
Medicure Inc. (MCUJF) Q4 2019 Earnings Conference Call April 16, 2020 10:00 AM ET Company Participants Albert Friesen – Chief Executive Officer James Kinley – Chief Financial Officer Neil Owens – President and Chief Operating Officer Conference Call Partic...
Medicure Reports Financial Results for Quarter and Year Ended December 31, 2019 Canada NewsWire WINNIPEG, April 15, 2020 WINNIPEG , April 15, 2020 /CNW/ - Medicure Inc. (" Medicure " or the " Company ") (TSXV:MPH, OTC:MCUJF), a pharmaceutical company, today reported ...
WINNIPEG , April 13, 2020 /PRNewswire/ - Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH, OTC:MCUJF), a cardiovascular pharmaceutical company, will release financial results for the year ended December 31, 2019 on Wednesday, April 15, 2020 . The financial statements will be ...
Early Warning News Release - Dr. Albert D. Friesen Holdings in Medicure Inc. Canada NewsWire WINNIPEG, Dec. 31, 2019 WINNIPEG , Dec. 31, 2019 /CNW/ - This press release is being issued in connection with the filing of an early warning report (the " Early Warning Report ")...
WINNIPEG , Dec. 20, 2019 /PRNewswire/ - Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH, OTC:MCUJF), a cardiovascular pharmaceutical company, announced today the preliminary results of its substantial issuer bid (the "Offer") to repurchase for cancellation up to 4.0 million of its c...
WINNIPEG , Dec. 17, 2019 /PRNewswire/ - Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH, OTC:MCUJF), a cardiovascular pharmaceutical company, is pleased to announce the completion of the Shortened AGGRASTAT ® (tirofiban hydrochloride) injection versus Integrilin ® (eptif...
WINNIPEG , Dec. 12, 2019 /PRNewswire/ - Medicure Inc. ("Medicure" or the "Company") (TSXV: MPH), (OTC: MCUJF), a cardiovascular pharmaceutical company, is pleased to announce the completion of the FABOLUS-FASTER Phase 4 trial, a randomized, open-label, multi-center trial assessi...
WINNIPEG , Dec. 5, 2019 /PRNewswire/ - Medicure Inc. (" Medicure " or the " Company ") (TSXV:MPH, OTC:MCUJF), a cardiovascular pharmaceutical company, today announced that it has reached a settlement agreement with the purchaser of Medicure's interests in Apicore with respect to the amoun...
Medicure Files Patent Infringement Action Canada NewsWire WINNIPEG, Dec. 5, 2019 WINNIPEG , Dec. 5, 2019 /CNW/ - Medicure Inc. (" Medicure ") (TSXV: MPH, OTC: MCUJF), a cardiovascular pharmaceutical company, today announces that its subsidiary, Medicure International Inc....
News, Short Squeeze, Breakout and More Instantly...
WINNIPEG, MB / ACCESSWIRE / June 24, 2024 / Medicure Inc. (" Medicure " or the " Company ") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today announces ...
WINNIPEG, MB / ACCESSWIRE / May 28, 2024 / Medicure Inc. (" Medicure " or the " Company ") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today reported it...
Toto Ltd ADR (TOTDY) is expected to report for Q4 2024 NSK Ltd. ADR (NPSKY) is expected to report for Q4 2024 Monarch Cement Co. (MCEM) is expected to report for Q1 2024 HST Global Inc (HSTC) is expected to report for Q1 2024 Sumitomo Heavy Industries Ltd. ADR (SOHVY) is expected ...